Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCD-080 vs Clexane for DVT Prophylaxis in Orthopedic Surgery
NCT02368314Phase 3Completed
- Sponsor
- BIOCAD
- Start
- Jan 2015
- Primary completion
- Dec 2015
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in deep vein thrombosis (DVT), pulmonary embolism (PE), sponsored by BIOCAD. Started Jan 2015; status: completed.
02
Drugs
enoxaparin
03
Conditions
deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT02368314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02368314.